On July 24, Scott moderated and participated in a panel at DRI’s second annual Government Enforcement and Corporate Compliance seminar entitled “Medical Device and Pharmaceutical Industries Update.”  This panel, which included a federal prosecutor and an in-house lawyer from a major pharmaceutical company, discussed recent enforcement actions by the government and enforcement trends affecting the pharmaceutical and medical device industries.

Source: DRI Government Enforcement Seminar